Drugs / GEH120714
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01738347 | Apr 2013 → May 2016 | relapsing-remitting multiple sclerosis | GE Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEH120714 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01738347 ↗ |
| Route | Intravenous | “single intravenous administration” NCT01738347 ↗ |